Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon beta-1a

---

Kalincik T., Brown J. W., Robertson N., Willis M., Scolding N., Pearson O., ...More

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, vol.22, pp.829-832, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 22
• City: London
• Country: Canada
• Page Numbers: pp.829-832
• Karadeniz Technical University Affiliated: Yes